Ribonuclease L mediates the cell-lethal phenotype of double-stranded RNA editing enzyme ADAR1 deficiency in a human cell line. Author Yize Li, Shuvojit Banerjee, Stephen Goldstein, Beihua Dong, Christina Gaughan, Sneha Rath, Jesse Donovan, Alexei Korennykh, Robert Silverman, Susan Weiss Publication Year 2017 Type Journal Article Abstract ADAR1 isoforms are adenosine deaminases that edit and destabilize double-stranded RNA reducing its immunostimulatory activities. Mutation of leads to a severe neurodevelopmental and inflammatory disease of children, Aicardi-Goutiéres syndrome. In mice, mutations are embryonic lethal but are rescued by mutation of the or genes, which function in IFN induction. However, the specific IFN regulated proteins responsible for the pathogenic effects of mutation are unknown. We show that the cell-lethal phenotype of deletion in human lung adenocarcinoma A549 cells is rescued by CRISPR/Cas9 mutagenesis of the gene or by expression of the RNase L antagonist, murine coronavirus NS2 accessory protein. Our result demonstrate that ablation of RNase L activity promotes survival of ADAR1 deficient cells even in the presence of MDA5 and MAVS, suggesting that the RNase L system is the primary sensor pathway for endogenous dsRNA that leads to cell death. Keywords RNA-Binding Proteins, Humans, Cell Line, Tumor, Epithelial Cells, Endoribonucleases, Adaptor Proteins, Signal Transducing, Adenosine Deaminase, Cell Death, Interferon-Induced Helicase, IFIH1 Journal Elife Volume 6 Date Published 2017 Mar 31 ISSN Number 2050-084X DOI 10.7554/eLife.25687 Alternate Journal Elife PMCID PMC5404912 PMID 28362255 PubMedPubMed CentralGoogle ScholarBibTeXEndNote X3 XML